Difference between revisions of "Part:BBa K4012021"

(tENO2 in Level1 plasmid assembly)
 
(4 intermediate revisions by the same user not shown)
Line 28: Line 28:
  
 
[[Image:CDS_CsF3H.jpg|thumbnail|750px|center|'''Figure 2:'''  
 
[[Image:CDS_CsF3H.jpg|thumbnail|750px|center|'''Figure 2:'''  
[https://parts.igem.org/Part:BBa_K4012021] A: the construction strategy; B: results of colony PCR; C: results of sequencing analysis of coding sequence tENO2 demonstrated as Fig.2. The initiation of the tENO2 sequence is done by promoter pTEF1, with termination done by tENO2. The sequence ConL2 and ConR3 are connector sequences within the Level 1 plasmid assembly. Furthermore, typr9-KVF and type9-VR are imposed to enact selection through colonies PCR, results shown in Fig.2 The band length 2500bp match with expectations. The sequence analysis results show no significant mutations or deletions, representing the success of the assembly.
+
[https://parts.igem.org/Part:BBa_K4012021]] . The initiation of the CsF3H sequence is done by promoter pGAL7, with termination done by tENO2. The sequence ConL1 and ConR2 are connector sequences within the Level 1 plasmid assembly. Furthermore, typr9-KVF and type9-VR are imposed to enact selection through colonies PCR, results shown in Fig.2 The band length 2500bp match with expectations. The sequence analysis results show no significant mutations or deletions, representing the success of the assembly.
  
 
===tENO2 in Level2 plasmid assembly===
 
===tENO2 in Level2 plasmid assembly===
 
[[Image:yeast PCR.jpg|thumbnail|750px|center|'''Figure 3:'''  
 
[[Image:yeast PCR.jpg|thumbnail|750px|center|'''Figure 3:'''  
 
[https://parts.igem.org/Part:BBa_K4012021] A: The results of colony PCR of upstream transformant; B: The results of colony PCR of downstream transformant; C: Construction of catechin metabolic pathway; D:Construction of naringenin metabolic pathway]]
 
[https://parts.igem.org/Part:BBa_K4012021] A: The results of colony PCR of upstream transformant; B: The results of colony PCR of downstream transformant; C: Construction of catechin metabolic pathway; D:Construction of naringenin metabolic pathway]]
tENO2 is also involved in assembly of synthesis pathway of naringenin, shown by Fig.3.
+
tENO2 is also involved in assembly of synthesis pathway of catechin, shown by Fig.3.

Latest revision as of 14:14, 21 October 2021


Terminator.png

tENO2

  • it is a terminator that ends the sequence that is resposible for the production of Solenostemon scutellarioides flavanone 3-hydroxylase

Secondary Structure

File:Mfold-K4012021-1.png


Measurement

  • [http://openwetware.org/wiki/Cconboy:Terminator_Characterization/Results How these parts were measured]

Obtaining the fragment and BsaI digested verification

Figure 1: [1] Results of yeast toolkit plasmids enzyme-digested verification

We construct tENO2 with vector type8-pSB1K3-GFP and proceed digested verification using BsaI. According to Fig.1, we obtain two clear bands after BsaI digested, the length of the vector(1622bp) and the inserted fragments tENO2(238bp) matched with previous expectations by compared with Marker MK8000 ladder, confirming the successful assembly of Toolkit plasmids and availability in subsequent construction.

tENO2 in Level1 plasmid assembly

. The initiation of the CsF3H sequence is done by promoter pGAL7, with termination done by tENO2. The sequence ConL1 and ConR2 are connector sequences within the Level 1 plasmid assembly. Furthermore, typr9-KVF and type9-VR are imposed to enact selection through colonies PCR, results shown in Fig.2 The band length 2500bp match with expectations. The sequence analysis results show no significant mutations or deletions, representing the success of the assembly.

tENO2 in Level2 plasmid assembly

Figure 3: [2] A: The results of colony PCR of upstream transformant; B: The results of colony PCR of downstream transformant; C: Construction of catechin metabolic pathway; D:Construction of naringenin metabolic pathway

tENO2 is also involved in assembly of synthesis pathway of catechin, shown by Fig.3.